Predictors of three-month mortality and severe chemotherapy-related adverse events in patients aged 70 years and older with metastatic nonsmall-cell lung cancer: a secondary analysis of ESOGIA-GFPC-GECP 08-02 Study - Université Paris-Est-Créteil-Val-de-Marne Access content directly
Journal Articles Journal of Geriatric Oncology Year : 2023

Predictors of three-month mortality and severe chemotherapy-related adverse events in patients aged 70 years and older with metastatic nonsmall-cell lung cancer: a secondary analysis of ESOGIA-GFPC-GECP 08-02 Study

Jean-Bernard Auliac
  • Function : Author

Abstract

Predictors for mortality and toxicity in older patients with cancer are mainly studied in cohorts with various cancers at different stages. This study aims to identify predictive geriatric factors (PGFs) for early death and severe chemotherapy related adverse events (CRAEs) in patients aged ≥70 years with metastatic non-small-cell lung cancer (mNSCLC).
Embargoed file
Embargoed file
0 1 2
Year Month Jours
Avant la publication
Sunday, May 19, 2024
Embargoed file
Sunday, May 19, 2024
Please log in to request access to the document

Dates and versions

hal-04150041 , version 1 (04-07-2023)

Identifiers

Cite

Sébastien Gendarme, Sonia Zebachi, Romain Corre, Laurent Greillier, Grégoire Justeau, et al.. Predictors of three-month mortality and severe chemotherapy-related adverse events in patients aged 70 years and older with metastatic nonsmall-cell lung cancer: a secondary analysis of ESOGIA-GFPC-GECP 08-02 Study. Journal of Geriatric Oncology, 2023, pp.101506. ⟨10.1016/j.jgo.2023.101506⟩. ⟨hal-04150041⟩
15 View
7 Download

Altmetric

Share

Gmail Facebook X LinkedIn More